Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 0 | 1,317 | 1,229 | 1,213 | 0 |
| Cost of Goods | N/A | 1,113 | 1,030 | 1,147 | N/A |
| Gross Profit | N/A | 204 | 199 | 66 | N/A |
| Operating Expenses | 0 | 1,080 | -1,000 | 1,316 | 0 |
| Operating Income | N/A | -763 | -792 | -1,102 | N/A |
| Interest Expense | 0 | 3 | 3 | 0 | 0 |
| Other Income | 0 | 213 | 795 | 0 | 0 |
| Pre-tax Income | 0 | -553 | 0 | -1,102 | 0 |
| Net Income Continuous | N/A | -553 | N/A | -1,102 | N/A |
| Net Income | $N/A | $-553 | $N/A | $-1,102 | $N/A |
| EPS Basic Total Ops | N/A | -0.20 | -0.20 | -0.40 | N/A |
| EPS Basic Continuous Ops | N/A | -0.19 | N/A | -0.42 | N/A |
| EPS Diluted Total Ops | N/A | -0.20 | -0.20 | -0.40 | N/A |
| EPS Diluted Continuous Ops | N/A | -0.19 | N/A | -0.42 | N/A |
| EBITDA(a) | $N/A | $-47 | $1,472 | $-1,102 | $N/A |